N-Gene

N Gene is a biotechnology company focused on developing pharmacological solutions that exploit the natural defense mechanisms of cells. The company's lead compound, BGP 15, targets cellular stress responses, including heat shock protein and mitochondrial stress responses. This approach has shown therapeutic effects in a variety of serious diseases that currently lack efficient treatments. N Gene operates in the biotechnology and pharmaceutical markets, serving medical professionals, researchers, and healthcare providers. The business model revolves around the development and commercialization of innovative drugs, generating revenue through licensing agreements, partnerships, and direct sales. By addressing mitochondrial stress and promoting protein homeostasis, N Gene aims to improve patient outcomes in conditions characterized by cellular stress.

Keywords: biotechnology, pharmacology, cellular stress, heat shock proteins, mitochondrial function, therapeutic effects, drug development, healthcare, protein homeostasis, BGP 15.